MB-SDWG@EC2608A

Shandong Weigao Group repurchased 120,000 shares of Medical Polymer

BlackRock Increases Holding in Weigao Group to 5.09%

Shandong Weigao Group Medical Polymers Shares Company Limited repurchased 140,000 shares

Weigao Group spent HK$838,600 to repurchase 160,000 shares

Weigao Blood Purification Plans to Issue Shares to Purchase 100% Equity of Weigao Prima

Weigao Group repurchased shares for HKD 556,000

Shandong Weigao Medical Polymer Co., Ltd. Repurchased Shares

Weigao Group Repurchased 615,200 Shares at HKD 5.18-5.25 per Share

Weigao Group repurchased 220,000 shares for HKD 1.215 million

Weigao Group repurchased 640,000 shares for HKD 3.3914 million

Wego Group to Acquire Full Equity of Weigao Pure by Issuing Shares

Weigao Group repurchased 1.08 million shares

Blood Purification Leader Aims to Acquire Weigao Prima for 8.511 billion Yuan, and Sand and Stone Equipment Leader Aims to Acquire Kazakhstan Silver Mine

Weigao Group repurchased 340,800 shares

Weigao Group repurchased 607,600 shares for about HKD 3.1692 million

Weigao Group repurchased 420,000 shares for HKD 2.282 million

Weigao Group repurchased 100,000 shares

Weigao Group Repurchased 80,000 Shares for HKD 443,800

Weigao Group repurchased 1.6 million H shares

Weigao Group repurchases 100,000 shares for HKD 533,600

NANFANG COMM

DRAGON MINING

KING'S STONE

LOTUS HORIZON

PUTIAN COMM

CMON

SINO GOLF HOLD

YUANHENG GAS

REGAL PARTNERS

LEADWAY TECH

01066

Shandong Weigao Group Medical Polymer Co. Ltd. has repurchased 120,000 shares at HKD 5.28 each, totaling approximately HKD 634,000. This transaction is part of their treasury shares acquisition.

Reuters

WEIGAO GROUP

Shandong Weigao Group Medical Polymer Co. Ltd. buys back 120,000 shares for HKD 634,000 at HKD 5.28 each

Goldman Sachs report indicates that the mainland healthcare sector will continue to be strong, but investors need to pay attention to the value of the R&D pipeline. Outperformance depends on key data and earnings visibility. Positive on CDMO companies, upgrading WuXi AppTec and WUXI XDC ratings to "Buy." A selective strategy is recommended for biotech and pharmaceutical companies, recommending SKB BIO-B, HENLIUS, and HANSOH PHARMA. The medical device sector maintains a neutral stance, recommending ANGELALIGN and WEIGAO GROUP. A cautious attitude is taken towards the medical services sector, downgrading HYGEIA HEALTH and JXR ratings

AASTOCKS

E Fund Hang Seng SCHK Innovative Drug ETF

Guotai CSI Bio-medicine ETF

China Universal CNI HK Connect Innovative Drugs Industry ETF

HANSOH PHARMA

ChinaAMC SSE Health Care ETF Initiating Fund

Penghua CSI HK Connect Health Care Composite ETF

SKB BIO-B

ChinaAMC SSE STAR Biology and Medicine ETF

KELUN PHARMA

HENLIUS

China Southern Hang Seng Biotech ETF(QDII)

Minsheng Royal CSI Biotechnology Theme ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Hwabao WP CSI Pharmaceuticals ETF

Yinhua CSI Innovative Drugs Industry ETF

Bosera Hang Seng Health Care ETF(QDII)

China Merchants CSI Biotechnology Theme ETF

ICBCCS SSE STAR Biology and Medicine ETF

HYGEIA HEALTH

Founder Fubon CSI Medicine and Medical Device Innovation ETF

Penghua SSE STAR Biology and Medicine ETF

ChinaAMC CSI Biotechnology Theme ETF

WuXi AppTec

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

ANGELALIGN

Dacheng CSI All Share Health Care Equipment and Services ETF

Hwabao WP CSI Medical Service ETF

E Fund CSI Biotechnology Theme ETF

Huaan Hang Seng Biotech ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

E Fund CSI 300 Health Care ETF

WUXI XDC

Ping An CSI Medicine and Medical Device Innovation ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

WUXI APPTEC

Bosera Hang Seng SCHK Innovative Drug Select ETF

Goldman Sachs: The mainland medical sector will rely more on data and profit visibility this year, optimistic about CDMO companies

Shandong Weigao Group Medical Polymer Co. Ltd. has repurchased 100,000 shares at HKD 5.19 each, totaling approximately HKD 519,400. The shares will be held as treasury shares. This announcement was published via the Issuer Information Service of the Hong Kong Stock Exchange.

Shandong Weigao Group Medical Polymer Co. Ltd. buys back 100,000 shares for HKD 519,400

Shandong Weigao Group Medical Polymer Co. Ltd. has repurchased 140,000 shares at a price of HKD 5.05 each, totaling approximately HKD 706,600. The shares will be held as treasury shares.

Shandong Weigao Group Medical Polymer Co. Ltd. buys back 140,000 shares for HKD 706,600 at HKD 5.05 each

Shandong Weigao Group Medical Polymer Co. Ltd. has repurchased 220,000 shares at an average price of HKD 4.99 each, totaling approximately HKD 1,097,000. The shares will be held as treasury shares. This announcement was published via the Issuer Information Service of the Hong Kong Stock Exchange.

Shandong Weigao Group Medical Polymer Co. Ltd. buys back 220,000 shares for HKD 1,097,000 at HKD 4.99 each

159898

562600

159883

Shandong Weigao Group Medical Polymer Co. Ltd. has repurchased 1,112,000 shares at an average price of HKD 5.05 each, totaling approximately HKD 5,616,580. The shares will be held as treasury shares following the transaction.

China Merchants CSI All Share Medical Apparatus and Instruments ETF

ChinaAMC CSI All Share Health Care Devices ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

Shandong Weigao Group Medical Polymer Co. Ltd. buys back 1,112,000 shares at HKD 5.05 each for HKD 5,616,580

Shandong Weigao Group Medical Polymer (SEHK:1066) has scheduled an Extraordinary General Meeting for February 12, 2026, to seek shareholder approval for significant structural changes. The company has seen a 30-day share price return of 5.41% and a 1-year total return of 13.02%, but a 3-year loss of 56.58%. Currently trading at HK$5.26, the stock has a P/E of 10.8x, below industry averages, suggesting it may be undervalued. A DCF analysis estimates a fair value of HK$14.21 per share, indicating potential upside, but investor sentiment remains cautious due to past performance and upcoming changes.

Simplywall

A Look At Shandong Weigao Group Medical Polymer’s Valuation As Major EGM Transactions Are Proposed

Shandong Weigao Group Medical Polymer Co. Ltd. has repurchased 160,000 shares at an average price of HKD 5.24 each, totaling approximately HKD 838,600. The shares will be held as treasury shares. This announcement was published via the Hong Kong Stock Exchange.

Shandong Weigao Group Medical Polymer Co. Ltd. Buys Back 160,000 Shares for HKD 838,600 at HKD 5.24 Each

Shandong Weigao Group Medical Polymer Co. Ltd. has repurchased 160,000 shares at HKD 5.19 each, totaling approximately HKD 830,200. The shares will be held as treasury shares. This information was published via the Hong Kong Stock Exchange.

Shandong Weigao Group Medical Polymer Co. Ltd. repurchases 160,000 shares for HKD 830,200 at HKD 5.19 each

Shandong Weigao Group Medical Polymer Co. Ltd. has repurchased 260,000 shares at HKD 5.14 each, totaling approximately HKD 1,337,400. The shares will be held as treasury shares. This information was published via the Issuer Information Service by the Hong Kong Stock Exchange.

Shandong Weigao Group Medical Polymer Co. Ltd. buys back 260,000 shares for HKD 1,337,400 at HKD 5.14 each

Shandong Weigao Group Medical Polymer Co. Ltd. has repurchased 108,800 shares at HKD 5.11 each, totaling approximately HKD 555,968. The shares will be held as treasury shares. This announcement was published via the Hong Kong Stock Exchange.

Shandong Weigao Group Medical Polymer Co. Ltd. repurchases 108,800 shares for HKD 555,968

Shandong Weigao Group Medical Polymer Co. Ltd. will hold its first extraordinary general meeting on February 12, 2026, in Weihai, Shandong Province. Shareholders will vote on the approval of several agreements dated January 5, 2026, including the Sale and Purchase Agreement and the Compensation Agreement. The meeting will also authorize a director to take necessary actions related to these transactions.

Shandong Weigao Group Medical Polymer Co. Ltd. Announces Date for First Extraordinary General Meeting

Shandong Weigao Group Medical Polymer Co. Ltd. has repurchased 282,000 shares at HKD 5.13 each, totaling approximately HKD 1,446,320. The shares will be held as treasury shares. This announcement was published via the Issuer Information Service of the Hong Kong Stock Exchange.

Shandong Weigao Group Medical Polymer Co. Ltd. repurchases 282,000 shares for HKD 1,446,320 at HKD 5.13 each

WEIGAO GROUP (1066.HK) maintained pressure at the lower Bollinger Band throughout yesterday, with downward price pressure showing no signs of easing. The pharmaceutical sector continues to be troubled by policy pressures such as price limits and new centralized procurement regulations, which the market interprets as a compression of profitability for mid-range consumable companies, leading to a significant increase in risk-averse sentiment among investors. The apparent buying power from major players is weak, with short-term trading dominated by bargain-hunting funds, and a strong rebound lacks lasting momentum. The MACD continues to expand downward, and the moving average system shows significant resistance, with the price near 4.97 yuan being precarious, indicating a clear inertia for short-term declines. Smaller stocks are following suit with even more intense selling, highlighting a defensive style in the pharmaceutical sector. Attention should be paid to any potential slowdown in centralized procurement policies or self-rescue announcements from the company, as structural rebound speculation may occur. If trading volume continues to shrink and support is lost, the decline may reach a new phase low, with high-position liquidation potentially increasing at any time. The strategy recommendation is to remain on the sidelines, waiting for a recovery in trading volume and marginal policy changes in the sector

Technical Forecast

Morning Trend | WEIGAO GROUP faces pressure on support, is a downward trend about to return?

MB-SDWG@EC2608A(15480.HK)

Shandong Weigao Group Medical Polymer Co. Ltd. buys back 120,000 shares for HKD 634,000 at HKD 5.28 each

Goldman Sachs: The mainland medical sector will rely more on data and profit visibility this year, optimistic about CDMO companies

Shandong Weigao Group Medical Polymer Co. Ltd. buys back 100,000 shares for HKD 519,400

Shandong Weigao Group Medical Polymer Co. Ltd. buys back 140,000 shares for HKD 706,600 at HKD 5.05 each

Shandong Weigao Group Medical Polymer Co. Ltd. buys back 220,000 shares for HKD 1,097,000 at HKD 4.99 each